The use of PDE4D in the screening for medicaments against atherosclerosis

Details for Australian Patent Application No. 2004227089 (hide)

Owner F. Hoffmann-La Roche AG Decode Genetics EFH.

Inventors Evers, Stefan; Himber, Jacques; Gulcher, Jeffrey R.; Fingerle, Juergen; Gretarsdottir, Solveig

Agent Spruson & Ferguson

Pub. Number AU-A-2004227089

PCT Pub. Number WO2004/090157

Priority 03007993.3 10.04.03 EP

Filing date 7 April 2004

Wipo publication date 21 October 2004

International Classifications

A61P 009/00 Drugs for disorders of the cardiovascular system

A61K 038/00 Medicinal preparations containing peptides

A61K 031/00

A61K 039/00 Medicinal preparations containing antigens or antibodies

C07K 016/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 009/16 Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12Q 001/34 Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/090157 Priority application(s): WO2004/090157

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227095-Fuel composition

2004227085-Backflow preventer